Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now
Download Presentation
PPT-MM-005: A Phase 1, Multicenter, Open-Label, Dose-Escalation Study

PPT-MM-005: A Phase 1, Multicenter, Open-Label, Dose-Escalation Study

Author : chiquity | Published Date : 2020-06-16

to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide Bortezomib and Low Dose Dexamethasone in Patients with Relapsed or RelapsedRefractory

btz pom dose patients pom btz patients dose abstract proc dex richardson cohort ash response combination phase

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "MM-005: A Phase 1, Multicenter, Open-Lab..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

MM-005: A Phase 1, Multicenter, Open-Label, Dose-Escalation Study: Transcript

Show More

Related Contents

March 29, 2011
March 29, 2011
tatyana-admore
Phase I and Phase II trial design in
Phase I and Phase II trial design in
tatiana-dople
An APC activator (IMP321 or LAG-3Ig) combined with anti-PD
An APC activator (IMP321 or LAG-3Ig) combined with anti-PD
yoshiko-marsland
How to Find and Participate in a GIST clinical trial
How to Find and Participate in a GIST clinical trial
ellena-manuel
Open-label
Open-label
pamella-moone
Phase I Trial Designs Jud Blatchford, PhD
Phase I Trial Designs Jud Blatchford, PhD
faustina-dinatale
Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic
Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic
alexa-scheidler
Study 307- Long term open label extension data
Study 307- Long term open label extension data
windbey
A Phase Ib Dose Escalation Trial of SAR650984 (Anti-CD-38 mAb) in Combination with Lenalidomide
A Phase Ib Dose Escalation Trial of SAR650984 (Anti-CD-38 mAb) in Combination with Lenalidomide
scoopulachanel
Edward Fox, MD, PhD Phase 2 Multicenter Study Results of
Edward Fox, MD, PhD Phase 2 Multicenter Study Results of
medmacr
MErCuRIC1: A phase 1 Multi-Centre Study of
MErCuRIC1: A phase 1 Multi-Centre Study of
badra
Abstract #323 : An open-label, dose escalation, Phase I/II study to assess safety, tolerability,
Abstract #323 : An open-label, dose escalation, Phase I/II study to assess safety, tolerability,
caitlin
Posters: 1 Minute Previews
Posters: 1 Minute Previews
elina

Copyright © 2025 DocSlides. All Rights Reserved